Alkem Laboratories Limited (BOM: 539523)

Alkem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	19,523	4,551	2,738	2,322	1,742	1,759
Short-Term Investments	3,366	36,710	7,339	9,424	14,123	1,163
Trading Asset Securities	-	1,436	1,355	1,385	1,671	1,681
Cash & Short-Term Investments	22,889	42,697	11,432	13,130	17,537	4,603
Cash Growth	-36.59%	273.50%	-12.94%	-25.13%	281.00%	-29.64%
Accounts Receivable	24,981	22,855	21,442	18,880	16,072	16,494
Other Receivables	-	1,658	1,782	1,607	2,829	2,336
Receivables	25,128	24,603	23,292	20,689	19,088	19,110
Inventory	29,122	26,612	26,075	30,055	23,124	18,188
Prepaid Expenses	-	499.1	443.9	564.4	303.6	318.1
Other Current Assets	33,954	9,704	26,054	19,915	9,235	12,838
Total Current Assets	111,093	104,116	87,297	84,354	69,288	55,057
Property, Plant & Equipment	25,612	25,570	25,135	27,659	27,064	27,741
Long-Term Investments	10,983	4,051	5,249	8,803	1,586	1,119
Goodwill	4,192	4,167	4,132	4,031	3,954	3,985
Other Intangible Assets	1,182	575.8	793.9	721.9	844.4	984.1
Long-Term Deferred Tax Assets	16,533	15,148	13,025	13,093	11,079	9,326
Other Long-Term Assets	1,577	2,120	1,855	1,950	1,297	1,138
Total Assets	171,170	155,749	137,567	140,692	115,193	99,455
Accounts Payable	18,863	17,481	11,650	11,734	10,694	9,541
Accrued Expenses	-	8,506	9,248	7,941	6,443	5,237
Short-Term Debt	-	11,726	13,071	25,706	16,360	15,035
Current Portion of Long-Term Debt	11,103	13.4	0.3	1.2	368.3	381
Current Portion of Leases	283	151.8	192	216	215.5	218.2
Current Income Taxes Payable	862.7	549.9	234.4	163.2	189.3	381.7
Current Unearned Revenue	-	39.1	10.5	12.4	16.8	19.4
Other Current Liabilities	10,665	1,478	2,665	2,280	1,754	1,633
Total Current Liabilities	41,776	39,946	37,072	48,053	36,041	32,446
Long-Term Debt	1,260	400	-	93.8	279.3	675.9
Long-Term Leases	2,133	1,893	703.3	664.7	697.1	916.5
Long-Term Unearned Revenue	-	258.4	88	79.2	88.3	97.7
Other Long-Term Liabilities	6,901	4,178	3,652	1,775	1,311	1,048
Total Liabilities	52,070	48,605	43,217	52,219	39,613	36,366
Common Stock	239.1	239.1	239.1	239.1	239.1	239.1
Retained Earnings	-	102,970	90,392	85,811	73,540	61,037
Comprehensive Income & Other	114,689	-88	-178.4	328.5	-11.8	330.2
Total Common Equity	114,929	103,121	90,453	86,379	73,767	61,607
Minority Interest	4,172	4,023	3,897	2,094	1,813	1,483
Shareholders' Equity	119,101	107,144	94,350	88,473	75,580	63,090
Total Liabilities & Equity	171,170	155,749	137,567	140,692	115,193	99,455
Total Debt	14,779	14,184	13,967	26,682	17,920	17,227
Net Cash (Debt)	8,110	28,513	-2,535	-13,552	-382.8	-12,624
Net Cash Per Share	67.83	238.47	-21.20	-113.34	-3.20	-105.58
Filing Date Shares Outstanding	119.56	119.57	119.57	119.57	119.57	119.57
Total Common Shares Outstanding	119.56	119.57	119.57	119.57	119.57	119.57
Working Capital	69,317	64,170	50,225	36,301	33,248	22,611
Book Value Per Share	961.30	862.46	756.52	722.44	616.96	515.26
Tangible Book Value	109,555	98,377	85,527	81,626	68,969	56,638
Tangible Book Value Per Share	916.35	822.79	715.32	682.69	576.83	473.70
Land	-	1,472	1,369	1,373	2,014	2,017
Buildings	-	10,226	8,786	9,672	8,807	8,635
Machinery	-	23,690	21,710	22,554	19,732	18,335
Construction In Progress	-	1,484	3,103	3,395	3,933	3,630

Source: S&P Capital IQ. Standard template. Financial Sources.